Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation.
Blocking a specific protein shows promise for destroying leukemia stem cells, pointing toward a new drug strategy for treating acute myeloid leukemia.
This PubMed record examines Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation. The abstract's reported finding is: Collectively, our findings establish NUP214 as a critical oncoprotein that orchestrates heme metabolism and lipid peroxidation to sustain LSCs, and highlight NUP214-targeted degradation as a promising intervention strategy for AML.
What the study was
- Study design
- Observational or experimental study
- Population
- Human participants; details in abstract
- Category
- Other
- Maturity
- Exploratory
- Journal
- Blood
Why it surfaced
Retained as a 8/10 high-priority match for Hematologic malignancies; scoring is conservative because triage used the PubMed abstract without full-text review.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.